Construction of a novel six-gene signature to predict tumour response to induction chemotherapy and overall survival in locoregionally advanced laryngeal and hypopharyngeal carcinoma
- PMID: 38292204
- PMCID: PMC10825302
- DOI: 10.1016/j.gendis.2023.05.018
Construction of a novel six-gene signature to predict tumour response to induction chemotherapy and overall survival in locoregionally advanced laryngeal and hypopharyngeal carcinoma
Figures
References
-
- Department of Veterans Affairs Laryngeal Cancer Study Group. Wolf G.T., Fisher S.G., et al. Induction chemotherapy plus radiation compared with surgery plus radiation in patients with advanced laryngeal cancer. N Engl J Med. 1991;324(24):1685–1690. - PubMed
-
- Bozec A., Benezery K., Ettaiche M., et al. Induction chemotherapy-based larynx preservation program for locally advanced hypopharyngeal cancer: Oncologic and functional outcomes and prognostic factors. Eur Arch Otorhinolaryngol. 2016;273(10):3299–3306. - PubMed
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
